NASDAQ : MBOT
Microbot Medical Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 1.12 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 75.22M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 69.85M |
| Enterprise Value | 3.36M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 67.16M |
| Shares Outstanding | 67.16M |
| Shares Change (YoY) | +146.72% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 17.57% |
| Float | 67.16M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 201.88 |
| Forward PS | 27.62 |
| PB Ratio | 1.01 |
| P/TBV Ratio | 1.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 9.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 18.56 |
| Quick Ratio | 17.37 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -32.91% |
| Return on Assets (ROA) | -21.72% |
| Return on Invested Capital (ROIC) | -23.06% |
| Return on Capital Employed (ROCE) | -26.64% |
| Weighted Average Cost of Capital (WACC) | 9.79% |
| Revenue Per Employee | $8,047 |
| Profits Per Employee | -$379,977 |
| Employee Count | 43 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.03 |
| 52-Week Price Change | -53.36% |
| 50-Day Moving Average | 1.24 |
| 200-Day Moving Average | 1.84 |
| Relative Strength Index (RSI) | 43.01 |
| Average Volume (20 Days) | 840,750 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 5.99M |
| Short Previous Month | 6.64M |
| Short % of Shares Out | 8.92% |
| Short % of Float | 8.92% |
| Short Ratio (days to cover) | 8.33 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 346,000 |
| Gross Profit | -641,000 |
| Operating Income | -18.51M |
| Pretax Income | -16.34M |
| Net Income | -16.34M |
| EBITDA | -18.46M |
| EBIT | -18.51M |
| Loss Per Share | -$0.26 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 67.37M |
| Total Debt | 876,000 |
| Net Cash | 66.49M |
| Net Cash Per Share | $0.99 |
| Equity (Book Value) | 68.93M |
| Book Value Per Share | 1.03 |
| Working Capital | 68.29M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -17.64M |
| Capital Expenditures | -288,000 |
| Depreciation & Amortization | 47,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -17.93M |
| FCF Per Share | -$0.27 |
Margins
| Measure | Value |
|---|
| Gross Margin | -185.26% |
| Operating Margin | -5,348.84% |
| Pretax Margin | -4,722.25% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -146.72% |
| Shareholder Yield | -146.72% |
| Earnings Yield | -25.15% |
| FCF Yield | -25.67% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $5.38 |
| Price Target Difference | 416.83% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Sep 5, 2018 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 18.28 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |